Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyrrolidine derivative, its preparation method and application thereof

A technology of pyrrolidine and derivatives, applied in drug combination, nervous system diseases, organic chemistry, etc., can solve the problems of slow onset, poor patient compliance, and many side effects, to reduce side effects, enhance curative effect, and have a good application prospect. Effect

Inactive Publication Date: 2015-04-08
SHANGHAI INST OF PHARMA IND CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is to overcome the defects of antidepressants in the prior art that are only effective for some patients, slow onset, poor patient compliance and many side effects, and provide a class of pyrrolidine derivatives, its preparation Method, its application in the preparation of antidepressant medicine and its pharmaceutical composition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrrolidine derivative, its preparation method and application thereof
  • Pyrrolidine derivative, its preparation method and application thereof
  • Pyrrolidine derivative, its preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 Preparation of tert-butyl 3-phenyl-3-hydroxypyrrolidine-1-carboxylate

[0035]

[0036] 4.71 g of bromobenzene and 14 ml of n-BuLi (2.26M hexane solution) were dissolved in anhydrous THF (10 ml), cooled to -40°C and stirred. After 1 h, the temperature was raised to 0° C., an anhydrous THF solution (10 ml) of 5.55 g of N-Boc-3-pyrrolidone was added dropwise, and the mixture was returned to room temperature and stirred for 10 min. Pour the reaction system into saturated NH 4 In the Cl solution, adjust the pH=6, extract with ethyl acetate, separate the liquids, repeat the extraction of the aqueous phase with ethyl acetate twice (10ml×2), combine the organic phases, anhydrous Na 2 SO 4 Dry, filter, and concentrate to a dark red oil. Flash silica gel column (ethyl acetate / petroleum ether=15%-25%) eluted to give 2.05 g of tert-butyl 3-phenyl-3-hydroxypyrrolidine-1-carboxylate as a light yellow solid, MP (melting point)=133°C .

[0037] Its structural identif...

Embodiment 2

[0040] Example 2 Preparation of tert-butyl 3-(4-fluorophenyl)-3-hydroxypyrrolidine-1-carboxylate

[0041]

[0042] Stir 1.2g of Mg powder and 8.75g of 4-fluorobromobenzene in 10ml of anhydrous THF solution for 3h. Add 20 ml of anhydrous THF solution of 8.88 g of N-Boc-3-pyrrolidone dropwise, stir for 30 min, pour the system into saturated NH 4 Cl, extracted with ethyl acetate, separated, the aqueous phase was repeatedly extracted 3 times with ethyl acetate (10ml×3), the organic phase was combined, anhydrous Na 2 SO 4 Dry, filter, and concentrate to give a yellow solid. Isopropyl ether was recrystallized to obtain 10.2 g of tert-butyl 3-(4-fluorophenyl)-3-hydroxypyrrolidine-1-carboxylate as a light yellow powder solid, MP (melting point) = 130°C.

[0043] Its structural identification data are as follows:

[0044] ESI-MS=282(M+H);

[0045] 1 H-NMR (DMSO-d 6 , 400MHz): δ=1.51(9H, s), 1.94(1H, s), 2.21-2.29(2H, m), 3.66(4H, s), 7.06-7.10(2H, m), 7.46-7.50(2H , m).

Embodiment 3

[0046] Example 3 Preparation of tert-butyl 3-(1-naphthyl)-3-hydroxypyrrolidine-1-carboxylate

[0047]

[0048] 1.2 g of Mg powder and 10.4 g of 1-bromonaphthalene were stirred in anhydrous THF solution (10 ml) for 3 h. Anhydrous THF solution (20 ml) of 8.88 g of N-Boc-3-pyrrolidone was added dropwise, and stirred for 30 min. Pour the system into saturated NH 4 Cl, extracted with ethyl acetate, separated, the aqueous phase was repeatedly extracted 3 times with ethyl acetate (10ml×3), the organic phase was combined, anhydrous Na 2 SO 4 Dry, filter, and concentrate to give a yellow solid. Recrystallization from isopropyl ether gave 9.82 g of tert-butyl 3-(1-naphthyl)-3-hydroxypyrrolidine-1-carboxylate as a light yellow powder solid, MP (melting point) = 125°C.

[0049] Its structural identification data are as follows:

[0050] ESI-MS=314(M+H)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pyrrolidine derivative as shown in the formula I, its preparation method, an application of the pyrrolidine derivative in the preparation of antidepressant drugs, and a pharmaceutical composition containing the pyrrolidine derivative, wherein R1 is C6-C10 aryl group or 1-2 halogen atom substituted C6-C10 aryl group; R2 is a phenyl group, 1-2 halogen atom substituted phenyl group, 1-3 C1-C3 alkoxy substituted phenyl group, C5-C6 heteroaryl group, 1-2 halogen atom substituted C5-C6 heteroaryl group, 1-3 C1-C3 alkoxy substituted C5-C6 heteroaryl group or 1-3 C5-C6 heteroaryl substituted C1-C3 alkyl group. The pyrrolidine derivative and its pharmaceutically acceptable salts can have a triple reuptake inhibition effect on a 5-HT / DA / NE transporter, are used to prepare antidepressant drugs, can be used to shorten the onset time, enhance curative effects and minimize side effect, provide a novel approach for preventing and treating depression, and have a better application prospect.

Description

technical field [0001] The invention relates to a class of pyrrolidine derivatives, their preparation method and application. Background technique [0002] Depression is a common serious mental illness that can be caused by multiple complex factors. Patients often show a series of symptoms, such as depression, sleep disturbance, appetite disturbance, anxiety, constipation, and strong suicidal tendencies. According to the statistics of the World Health Organization (WHO), depression is one of the diseases with the highest disability rate in the world. The global prevalence is about 16.2%, and there is a gradual increase trend. [0003] The monoamine hypothesis originated from the antidepressant effects of imipramine and iproniazid discovered by accident in the 1960s, and was gradually developed on the basis of the research on the mechanism of action of clinically used drugs. Imipramine and iproniazid belong to tricyclic antidepressants and irreversible monoamine oxidase inh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D207/12C07D401/12A61K31/4439A61K31/4015A61P25/24
Inventor 吴刚岑均达
Owner SHANGHAI INST OF PHARMA IND CO LTD